Search

Search Constraints

You searched for: Author/Creator Salloway, Stephen P.

Search Results

1. [11C]PiB and [18F]AV45 PET radiotracers show different rates of amyloid‐β clearance. (31st December 2021)

3. Advancing combination therapy for Alzheimer's disease. Issue 1 (7th October 2020)

4. AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (20th December 2022)

5. AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (20th December 2022)

6. ALZ‐NET: Using Real World Evidence to Inform the Future of Alzheimer's Treatment and Care. (20th December 2022)

7. Amyloid and tau PET in sporadic early‐onset Alzheimer's disease: Preliminary results from LEADS: LEADS: Sporadic early‐onset Alzheimer's disease in the spotlight. (7th December 2020)

8. Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Issue 5 (13th October 2022)

9. Characterization of amyloid‐related imaging abnormality in the DIAN‐TU‐001 trial. (31st December 2021)

10. Clinical diagnosis of Alzheimer's disease: Recommendations of the International Working Group (IWG). (31st December 2021)